Radix astragali and radix rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability-promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissues

Phytotherapy Research

Volumn 23, Issue 6, 2009, Pages 809-815

  Lau, T W ^a   Chan, Y W ^a   Lau, C P ^a   Lau, K M ^a   Lau, C B S ^a   Fung, K P ^a   Leung, P C ^a   Ho, Yuan Yuan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese medicine; Diabetic mellitus; Fibroblast; Foot ulcer; Granulation tissue; Wound healing

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ASTRAGALUS EXTRACT; HERBACEOUS AGENT; REHMANNIA EXTRACT; INSULIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DIABETIC FOOT; DRUG ACTIVITY; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; PLANT ROOT; WOUND HEALING; ASTRAGALUS PLANT; CELL SURVIVAL; CHEMISTRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYTOTHERAPY; REHMANNIA;

ASTRAGALUS PLANT; CELL SURVIVAL; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DRUGS, CHINESE HERBAL; FIBROBLASTS; HUMANS; INSULIN; PHYTOTHERAPY; REHMANNIA; WOUND HEALING;

EID: 67149091203     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2649     Document Type: Article

References (43)

1. Adolphe M, Pointet Y, Ronot X, Wepierre J. 1984. Use of fibroblast cell culture for the study of wound healing drugs. Int J Cosmet Sci 61: 55-58. (Pubitemid 14185173)
2. Bernard FX, Barrault C, Juchaux F, Laurensou C, Apert L. 2005. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J Wound Care 14: 215-220.
3. Boulton AJM, Armstrong DG. 2005. Diabetic foot and ulceration: epidemiology and pathophysiology. In Wound Healing, Falabella AF, Kirsner RS (eds). Taylor & Francis group: New York, 171-181.
4. Bucalo B, Eaglstein WH, Falanga V. 1993. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1: 181-186.
5. Buntrock P, Buntrock M, Marx I, Kranz D, Jentzsch KD, Heder G. 1984. Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. III. Electron microscopy, autoradiography, and ultrastructural autoradiography of granulation tissue. Exp Pathol 26: 247-254.
6. Chang HM, But PH. 1986. Pharmacology and Applications of Chinese Materia Medica. World Scientific: Singapore.
7. Chin GA, Diegelmann RF, Schultz GS. 2005. Cellular and molecular regulation of wound healing. In Wound Healing, Falabella AF, Kirsner RS (eds). Taylor & Francis: New York, 17-37.
8. Chinese Pharmacopoeia Commission. 2005. Pharmacopoeia of the People's Republic of China (2005) Volume I. People's Medical Publishing House: Beijing, China.
9. Dudnikova GN. 1979. Stimulation of fibroblast proliferation during experimental wound healing. Bull Exp Biol Med 88: 906-908. (Pubitemid 10073774)
10. Dunning T. 2003. Care of People with Diabetes: A Manual of Nursing Practice. MA: Blackwell: Oxford, Malden.
11. Fu R, Zhu BW. 2004. Antioxidant activity detection of Radix Ligusticum, Radix Rhodiolae, and Radix Astragali by using DPPH method. J Dalian Institute of Light Industry 23: 114-117.
12. Hehenberger K, Hansson A. 1997. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem Funct 15: 197-201. (Pubitemid 27395286)
13. Hehenberger K, Hansson A, Heilborn JD, Abdelhalim SM, Ostensson C, Brismar K. 1999. Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus. Wound Repair Regen 7: 65-71. (Pubitemid 29159042)
14. Komorov IS, Fedotov VP. 1974. Effect of insulin on the proliferation and kinetics of mitotic cycle of the murine fibroblast (L) in vitro. Probl Endokrinol 20: 52-55.
15. Laato M, Kahari VM, Niinikoski J, Vuorio E. 1987. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem J 247: 385-388.
16. LaPointe MS, Batlle D. 2001. Cultured skin fibroblasts as an in vitro model to assess phenotypic features in subjects with diabetic nephropathy. Am J Kidney Dis 38: 646-648. (Pubitemid 32803078)
17. Lau TW, Chan YW, Lau CP et al. 2007. Investigation of the effects of Chinese medicine on fibroblast viability: implications in wound healing. Phytother Res 21: 938-947. (Pubitemid 47582767)
18. Levin ME. 2002. Management of the diabetic foot: preventing amputation. South Med J 95: 10-20. (Pubitemid 34131531)
19. Li Y. 2000. 158 cases of diabetes II treated with self-designed diabetes decoction-attaching the six kinds Rehmannia pill control group of 52 cases. Liao Ning J Tradit Chin Med 27: 252-253.
20. Loots MAM, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. 1999. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 291: 93-99. (Pubitemid 29116523)
21. Lu J, Zou D, Zhang J. 1999. Preventive effect of Radix Astragali on insulin resistance caused by tumor necrosis factor-alpha. Zhongguo Zhongxiyi Jiehe Zazhi 19: 420-422.
22. Margarson MP, Soni NC. 2005. Plasma volume measurement in septic patients using an albumin technique: comparison with the standard radio-labelled albumin method. Intensive Care Med 31: 289-295. (Pubitemid 40362280)
23. Martin-Ruiz C, Saretzki G, Petrie J et al. 2004. Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span. J Biol Chem 279: 17826-17833. (Pubitemid 38560550)
24. Miura T, Kako M, Ishihara E et al. 1997. Antidiabetic effect of seishin-kanro-to in KK-Ay mice. Planta Med 63: 320-322. (Pubitemid 27322423)
25. Mooney J, Merriman L. 1995. Assessment of the 'at risk' foot. In Assessment of the Lower Limb, Merriman L, Tollafield D (eds). Churchill Livingstone: Edinburgh, New York; 393-422.
26. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63. (Pubitemid 14203433)
27. Park SG, Shin H, Shin YK et al. 2005. The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol 166: 387-398. (Pubitemid 40189036)
28. Park YD, Kim SY, Jang HS et al. 2004. Towards a proteomic analysis of atopic dermatitis: A two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics 4: 3446-3455. (Pubitemid 39525294)
29. Prieto JM, Recio MC, Giner RM, Manez S, Giner-Larza EM, Rios JL. 2003. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol 55: 1275-1282. (Pubitemid 37180014)
30. Puricelli L, Iori E, Millioni R et al. 2006. Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J Clin Endocrinol 91: 3507-3514. (Pubitemid 44402129)
31. Rees RS, Adamson BF, Lindblad WJ. 2001. Use of a cell-based interactive wound dressing to enhance healing of excisional wounds in nude mice. Wound Repair Regen 9: 297-304. (Pubitemid 32954893)
32. Singer AJ, Hollander JE. 2003. Lacerations and Acute Wounds: An Evidence-based Guide. F.A. Davis: Philadelphia, PA.
33. Stewart MI, Bernhard JD, Cropley Fitzpatrick TB. 2003. The structure of skin lesions and fundamentals of diagnosis. In Fitzpatrick's Dermatology in General Medicine, 6th edn, Freedbery IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds). McGraw-Hill: New York, 11-30.
34. Wang WK, Hsu TL, Huang ZY, Wang YY. 1995. Collective effect of a Chinese formula - a study of xiao-jian-zhong-tang. Am J Chin Med 23: 299-304.
35. Wong MWN, Leung PC, Wong WC. 2001. Limb salvage in extensive diabetic foot ulceration - a preliminary clinical study using simple debridement and herbal drinks. Hong Kong Med J 7: 403-407.
36. World Health Organization. 2002. Diabetes: The Cost of Diabetes. Fact sheet: No. 236. WHO: Geneva, Switzerland.
37. Yan ZY. 2001. 35 cases of treating diabetes with Shenlingbaishu powder accompanied by glyburide. Hunan Guiding J TCMP 7: 301.
38. Yang XB, Huang ZM, Cao WB, Chen HY, Tian WH, Wang JH. 2002a. Effect of extract from Rhizoma Alismatis on normal and alloxan model in mice. Chin J Exp Trad Med Formulae 8: 24-25.
39. Yang XB, Huang ZM, Cao WB, Chen HY, Wang JH, Xu L. 2002b. Therapeutic and protective effects of water-ethanolic extract from Rhizoma Alismatis on streptozotocin-induced diabetic mice. Pharm J China PLA 18: 336-350.
40. Zhang RX, Jia ZP, Kong LY et al. 2004a. Stachyose extract from Rehmannia glutinosa Libosch. to lower plasma glucose in normal and diabetic rats by oral administration. Pharmazie 59: 552-556. (Pubitemid 38962829)
41. Zhang RX, Zhou JH, Jia ZP, Zhang YX, Gu GM. 2004b. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J Ethnopharmacol 90: 39-43.
42. Zhang SC. 1974. Antiinflammatory actions of 15 kinds of Chinese drugs. New Med J 4: 4346.
43. Zhang YD, Shen JP, Song J, Wang YL, Li DX. 1984. Effects on blood pressure and inflammation of Astragalus saponin I, isolated from Astragalus membranaceus Bge. Yao Xue Xue Bao 19: 333-337.